Literature DB >> 16980303

An exonic splicing silencer is involved in the regulated splicing of glucose 6-phosphate dehydrogenase mRNA.

Wioletta Szeszel-Fedorowicz1, Indrani Talukdar, Brian N Griffith, Callee M Walsh, Lisa M Salati.   

Abstract

The inhibition of glucose-6-phosphate dehydrogenase (G6PD) expression by arachidonic acid occurs by changes in the rate of pre-mRNA splicing. Here, we have identified a cis-acting RNA element required for regulated splicing of G6PD mRNA. Using transfection of G6PD RNA reporter constructs into rat hepatocytes, the cis-acting RNA element involved in this regulation was localized to nucleotides 43-72 of exon 12 in the G6PD mRNA. In in vitro splicing assays, RNA substrates containing exon 12 were not spliced. In contrast, RNA substrates containing other regions (exons 8 and 9 or exons 10 and 11) of the G6PD mRNA were efficiently spliced. Furthermore, exon 12 can inhibit splicing when substituted for other exons in RNA substrates that are readily spliced. This activity of the exon 12 regulatory element suggests that it is an exonic splicing silencer. Consistent with its activity as a splicing silencer, spliceosome assembly was inhibited on RNA substrates containing exon 12 compared with RNAs representing other regions of the G6PD transcript. Elimination of nucleotides 43-72 of exon 12 did not restore splicing of exon 12-containing RNA; thus, the 30-nucleotide element may not be exclusively a silencer. The binding of heterogeneous nuclear ribonucleoproteins K, L, and A2/B1 from both HeLa and hepatocyte nuclear extracts to the element further supports its activity as a silencer. In addition, SR proteins bind to the element, consistent with the presence of enhancer activity within this sequence. Thus, an exonic splicing silencer is involved in the inhibition of splicing of a constitutively spliced exon in the G6PD mRNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980303     DOI: 10.1074/jbc.M603825200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Role of precursor mRNA splicing in nutrient-induced alterations in gene expression and metabolism.

Authors:  Suhana Ravi; Rudolf J Schilder; Scot R Kimball
Journal:  J Nutr       Date:  2015-03-11       Impact factor: 4.798

2.  Serine arginine splicing factor 3 is involved in enhanced splicing of glucose-6-phosphate dehydrogenase RNA in response to nutrients and hormones in liver.

Authors:  Callee M Walsh; Amanda L Suchanek; Travis J Cyphert; Alison B Kohan; Wioletta Szeszel-Fedorowicz; Lisa M Salati
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

3.  Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.

Authors:  Kenneth J Dery; Shikha Gaur; Marieta Gencheva; Yun Yen; John E Shively; Rajesh K Gaur
Journal:  J Biol Chem       Date:  2011-03-11       Impact factor: 5.157

4.  Identification of hnRNPs K, L and A2/B1 as candidate proteins involved in the nutritional regulation of mRNA splicing.

Authors:  Brian N Griffith; Callee M Walsh; Wioletta Szeszel-Fedorowicz; Aaron T Timperman; Lisa M Salati
Journal:  Biochim Biophys Acta       Date:  2006-10-06

5.  Starvation actively inhibits splicing of glucose-6-phosphate dehydrogenase mRNA via a bifunctional ESE/ESS element bound by hnRNP K.

Authors:  T J Cyphert; A L Suchanek; B N Griffith; L M Salati
Journal:  Biochim Biophys Acta       Date:  2013-04-28

6.  3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.

Authors:  Eumorphia G Konstantakou; Gerassimos E Voutsinas; Athanassios D Velentzas; Aggeliki-Stefania Basogianni; Efthimios Paronis; Evangelos Balafas; Nikolaos Kostomitsopoulos; Konstantinos N Syrigos; Ema Anastasiadou; Dimitrios J Stravopodis
Journal:  Mol Cancer       Date:  2015-07-22       Impact factor: 27.401

7.  IRF-1 regulates alternative mRNA splicing of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in breast epithelial cells generating an immunoreceptor tyrosine-based inhibition motif (ITIM) containing isoform.

Authors:  Kenneth J Dery; Maciej Kujawski; David Grunert; Xiwei Wu; Tung Ngyuen; Celeste Cheung; John H Yim; John E Shively
Journal:  Mol Cancer       Date:  2014-03-21       Impact factor: 27.401

8.  Palmitate- and C6 ceramide-induced Tnnt3 pre-mRNA alternative splicing occurs in a PP2A dependent manner.

Authors:  Adam J Black; Rudolf J Schilder; Scot R Kimball
Journal:  Nutr Metab (Lond)       Date:  2018-12-17       Impact factor: 4.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.